We are live on ! Find out more
FLNA

Filana Therapeutics

175 hedge funds and large institutions have $439M invested in Filana Therapeutics in 2022 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 44 increasing their positions, 34 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 23

60% more call options, than puts

Call options by funds: $276M | Put options by funds: $173M

57% more capital invested

Capital invested by funds: $279M → $439M (+$160M)

29% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 34

17% more funds holding

Funds holding: 149175 (+26)

1.34% more ownership

Funds ownership: 24.89%26.23% (+1.3%)

Holders
175
Holders Change
+26
Holders Change %
+17.45%
% of All Funds
3.01%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
49
Increased
44
Reduced
34
Closed
23
Calls
$276M
Puts
$173M
Net Calls
+$103M
Net Calls Change
+$106M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$104M -$4.75M -175,999 -7%
Vanguard Group
2
Vanguard Group
Pennsylvania
$88.2M +$1.68M +62,151 +3%
State Street
3
State Street
Massachusetts
$41.7M -$76.1K -2,819 -0.3%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$28.6M +$305K +11,309 +2%
Northern Trust
5
Northern Trust
Illinois
$14.8M -$146K -5,409 -2%
Norges Bank
6
Norges Bank
Norway
$12.3M
Charles Schwab
7
Charles Schwab
California
$11.5M +$198K +7,327 +3%
Bank of America
8
Bank of America
North Carolina
$11.1M +$3.34M +123,547 +87%
Invesco
9
Invesco
Georgia
$10.7M +$6.49M +240,355 +1,528%
Morgan Stanley
10
Morgan Stanley
New York
$9.12M +$39.1K +1,446 +0.7%
Marshall Wace
11
Marshall Wace
United Kingdom
$6.58M +$4.25M +157,325 New
N
12
Nuveen
North Carolina
$6.45M -$149K -5,526 -3%
BNP Paribas Financial Markets
13
BNP Paribas Financial Markets
France
$5.4M -$2.49M -92,073 -42%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$5.39M +$335K +12,408 +11%
GC
15
GMT Capital
Georgia
$4.81M +$3.11M +115,100 New
TI
16
Think Investments
California
$4.67M
Swiss National Bank
17
Swiss National Bank
Switzerland
$3.75M
Goldman Sachs
18
Goldman Sachs
New York
$3.21M +$1.06M +39,238 +104%
SC
19
Sculptor Capital
New York
$3.16M +$2.04M +75,500 New
RJA
20
Raymond James & Associates
Florida
$2.45M +$369K +13,656 +30%
RhumbLine Advisers
21
RhumbLine Advisers
Massachusetts
$2.15M +$125K +4,625 +10%
Neuberger Berman Group
22
Neuberger Berman Group
New York
$2.01M +$1.94K +72 +0.2%
California State Teachers Retirement System (CalSTRS)
23
California State Teachers Retirement System (CalSTRS)
California
$2M -$21.6K -799 -2%
LPL Financial
24
LPL Financial
California
$1.67M -$109K -4,021 -9%
State of Wisconsin Investment Board
25
State of Wisconsin Investment Board
Wisconsin
$1.61M -$56K -2,073 -5%

FLNA Hedge Fund Activity: Q3 2022 in Review

175 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2022, worth a combined $439M — up 57% from $279M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new FLNA positions and 23 closed out — a net gain of 26 holders — while 44 added to existing stakes and 34 trimmed.

The largest buyer was Invesco, adding an estimated $6.49M. The largest seller was BlackRock, cutting an estimated $4.75M.

  • 175 institutional investors held Filana Therapeutics (FLNA) as of Q3 2022, up from 149 in Q2 2022.
  • Funds reported $439M of Filana Therapeutics stock for Q3 2022, up 57% quarter-over-quarter.
  • 49 funds opened new Filana Therapeutics positions in Q3 2022 and 23 closed out, a net change of +26 holders.
  • The largest Filana Therapeutics buyer in Q3 2022 was Invesco, an estimated $6.49M added.
  • The largest Filana Therapeutics seller in Q3 2022 was BlackRock, an estimated $4.75M sold.

Based on aggregated 13F filings for Q3 2022.